Affiliation:
1. Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, 4000 Liège, Belgium
Abstract
Abstract
Context: Prevalence data are important for assessing the burden of disease on the health care system; data on pituitary adenoma prevalence are very scarce.
Objective: The objective of the study was to measure the prevalence of clinically relevant pituitary adenomas in a well-defined population.
Design: This was a cross-sectional, intensive, case-finding study performed in three regions of the province of Liège, Belgium, to measure pituitary adenoma prevalence as of September 30, 2005.
Setting: The study was conducted in specialist and general medical practitioner patient populations, referral hospitals, and investigational centers.
Methods: Three demographically and geographically distinct districts of the province of Liège were delineated precisely using postal codes. Medical practitioners in these districts were recruited, and patients with pituitary adenomas under their care were identified. Diagnoses were confirmed after retrieval of clinical, hormonal, radiological, and pathological data; full demographic and therapeutic follow-up data were collected in all cases.
Results: Sixty-eight patients with clinically relevant pituitary adenomas were identified in a population of 71,972 individuals; the mean (± sd) prevalence was 94 ± 19.3 cases per 100,000 population (95% confidence interval, 72.2 to 115.8). The group was 67.6% female and had a mean age at diagnosis of 40.3 yr; 42.6% had macroadenomas and 55.9% underwent surgery. Prolactinomas comprised 66% of the group, with the rest having nonsecreting tumors (14.7%), somatotropinomas (13.2%), or Cushing’s disease (5.9%); 20.6% had hypopituitarism.
Conclusion: The prevalence of pituitary adenomas in the study population (one case in 1064 individuals) was more than 3.5–5 times that previously reported. This increased prevalence may have important implications when prioritizing funding for research and treatment of pituitary adenomas.
Subject
Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference18 articles.
1. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups;Davis;Neuro-oncol,2001
2. The prevalence of pituitary adenomas: a systematic review;Ezzat;Cancer,2004
3. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality;Nilsson;J Clin Endocrinol Metab,2000
4. Estimation and projections of cancer prevalence from cancer registry data;Verdecchia;Stat Med,2002
5. Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study;Verges;J Clin Endocrinol Metab,2002
Cited by
820 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献